Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients

15Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background. The peritoneal surface is an acknowledged locoregional failure site of abdominal malignancies. Previous treatment attempts with medical therapy alone did not result in long-term survival. During the last two decades, new treatment protocols combining cytoreductive surgery with perioperative intraperitoneal and intravenous cancer chemotherapy have demonstrated very encouraging clinical results. This paper aims to clarify the pharmacologic base underlying these treatment regimens. Materials and Methods. A review of the current pharmacologic data regarding these perioperative chemotherapy protocols was undertaken. Conclusions. There is a clear pharmacokinetic and pharmacodynamic rationale for perioperative intraperitoneal and intravenous cancer chemotherapy in peritoneal surface malignancy patients. © Copyright 2012 K. Van der Speeten et al.

Cite

CITATION STYLE

APA

Van Der Speeten, K., Govaerts, K., Stuart, O. A., & Sugarbaker, P. H. (2012). Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients. Gastroenterology Research and Practice. https://doi.org/10.1155/2012/378064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free